期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

临床药师对培美曲塞联合顺铂治疗非小细胞肺癌的药学监护 被引量：6

Pharmaceutical care for pemetrexed plus platinum in non-small cell lung cancer provided by clinical pharmacists
原文传递
导出
摘要 结合临床药师在药物治疗、给药环节及患者用药教育等方面的工作体会,本文探讨临床药师在应用培美曲塞联合顺铂治疗非小细胞肺癌患者中开展药学服务的工作模式和切入点。 Combined with the experience of clinical pharmacists about drug treatment, administration step, medication education for patient, this review summarizes the working pattern and key points of clinical pharmacists during pharmaceutical care ofpemetrexed plus platinum in non-small cell lung cancer.
作者 徐志英
机构地区 张家港市第一人民医院药剂科
出处 《世界临床药物》 CAS 2012年第12期763-766,共4页 World Clinical Drug
关键词 培美曲塞 顺铂 非小细胞肺癌 药学监护 pemetrexed platinum non-small cell lung cancer pharmaceutical care
分类号 R979.1 [医药卫生—药品] R734.2 [医药卫生—肿瘤]
  • 相关文献

参考文献5

二级参考文献63

  • 1周红凤,吴瑾,王翠华,陈建华.奈达铂为主的联合方案治疗晚期非小细胞肺癌和食管癌[J].临床肿瘤学杂志,2005,10(1):82-83. 被引量：21
  • 2Fossella FV, DeVore R, Kerr RN, et al. Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.J Clin Oncol, 2000.18(12): 2354-2362.
  • 3Shepherd FA, Dancey J, Ramlau R, et al. Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-ceU lung cancer previously treated with platinum-based chemotherapy. Clin Oncol, 2000,18(10): 2095-2103.
  • 4Hanna N, Shepherd FA, Fossella FV, et al. Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy. J Clin Oncol, 2004, 22(9): 1589-1597.
  • 5NSCLC Meta-Analyses Collaborative Group. Chemotherapyin addition to supportive care improves survival in advanced non-small-cell lung cancer: a systematic review and meta-analysis of individual patient data from 16 randomized controUed trials. J Clin Oncol, 2008, 26(28): 4617-4625.
  • 6Carney DN. Lung cancer-time to move on from chemotherapy. New EnglJ Med, 2002, 346(2): 126-128.
  • 7Jemal A, Siegel R, Ward E, et al. Cancer statistics. CA Cancer J Clin. 2009, 59(4): 225-249.
  • 8Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell. 2000, 103(2): 211-225.
  • 9Ciardiello F, Tortora G. EGFR antagonists in cancer treatment. New EnglJ Med, 2008, 358(11): 1160-1174.
  • 10Shepherd FA, Rodrigues PJ, Ciuleanu T, et al Erlotinib in previously treated non-small-cell lung cancer. N EnglJ Med, 2005, 353(2): 123-132.

共引文献23

同被引文献43

引证文献6

二级引证文献26

世界临床药物
2012年 第12期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部